skip to main content
Guest
e-Shelf
My Account
Sign out
Sign in
This feature requires javascript
New Search
Journals by Title
Help
Language:
English
Français
Deutsch
This feature required javascript
This feature requires javascript
Primo Search
Great Falls College MSU
Great Falls College MSU
TRAILS Collections
MT Academic Libraries
EBSCO
EBSCO
Search For:
Clear Search Box
Search in:
Great Falls College MSU
Or hit Enter to replace search target
Or select another collection:
Search in:
Great Falls College MSU
Search in:
Great Falls College MSU Print Collection
Search in:
Great Falls College MSU Course Reserves
Advanced Search
Browse Search
This feature requires javascript
This feature requires javascript
Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management
Patriarcheas, Vasileios ; Pikoulas, Antonios ; Kostis, Minas ; Charpidou, Andriani ; Dimakakos, Evangelos
Curēus (Palo Alto, CA), 2020-03-24, Vol.12 (3), p.e7385-e7385
[Peer Reviewed Journal]
Full text available
Citations
Cited by
View Online
Details
Recommendations
Availability
Times Cited
This feature requires javascript
Actions
Add to e-Shelf
Remove from e-Shelf
E-mail
Print
Permalink
Citation
EasyBib
EndNote
RefWorks
Delicious
Export RIS
Export BibTeX
This feature requires javascript
Title:
Heparin-induced Thrombocytopenia: Pathophysiology, Diagnosis and Management
Author:
Patriarcheas, Vasileios
;
Pikoulas, Antonios
;
Kostis, Minas
;
Charpidou, Andriani
;
Dimakakos, Evangelos
Subjects:
Anticoagulants
;
Immunoglobulins
;
Heart attacks
;
Blood platelets
;
Laboratories
;
Pathogenesis
;
Embolisms
;
Thrombosis
Is Part Of:
Curēus (Palo Alto, CA), 2020-03-24, Vol.12 (3), p.e7385-e7385
Description:
Heparin-induced thrombocytopenia (HIT), even rare, is a life-threatening, immune-mediated complication of heparin exposure. It is considered the most severe non-bleeding adverse reaction of heparin treatment and one of the most important adverse drug reactions. The pathophysiological basis of HIT results from the formation of an immunocomplex consisting of an auto-antibody against platelet factor 4 (PF4) - heparin complex, which binds to the surface of platelets and monocytes, provoking their activation by cross-linking FcgIIA receptors. Platelets and monocyte activation, leads to the generation of catastrophic arterial and venous thrombosis, with a mortality rate of 20%, without early recognition. The definitive diagnosis of HIT i.e., clinical and laboratory evidence, can not be done at the onset of symptoms because laboratory results may not be available for several days. Thus, the initial approach is to predict the likelihood of HIT, because in highly suspected patients immediate heparin cessation and initiation of alternative anticoagulation treatment are crucial for the prevention of the devastating thrombotic sequelae. Herein, we describe the pathophysiology, the clinical manifestations, the diagnostic approach, and the management of patients with HIT.
Publisher:
United States: Cureus Inc
Language:
English
Identifier:
ISSN:
2168-8184
EISSN:
2168-8184
DOI:
10.7759/cureus.7385
PMID:
32337112
Source:
© ProQuest LLC All rights reserved
Show collections
Hide collections
This feature requires javascript
This feature requires javascript
Back to results list
This feature requires javascript
This feature requires javascript
Searching Remote Databases, Please Wait
Searching for
in
scope:(01TRAILS_MSU_GFC),primo_central_multiple_fe
Show me what you have so far
This feature requires javascript
This feature requires javascript